Channing Der is an expert in the field of so-called RAS genes, which play an important role regarding the control of cancer cell growth. The oncologist, who holds a professorship at the University of Carolina in Chapel Hill, continues his research at the Institute of Pathology at Charité-Universitätsmedizin Berlin. The aim of Der’s research project is to improve the treatment of tumor patients, establishing a more personalised and effective therapy.
The Einstein BIH Visiting Fellows Program is a cooperation of Charité Foundation and Einstein Foundation Berlin. An Einstein BIH Visiting Fellowship is awarded to internationally renowned researchers who support the Berlin Institute of Health / BIH with their scientific expertise.
Read more about Channing’s award here. (Site is in German.)